Monte Rosa Therapeutics
GLUE
GLUE
70 hedge funds and large institutions have $328M invested in Monte Rosa Therapeutics in 2022 Q3 according to their latest regulatory filings, with 16 funds opening new positions, 21 increasing their positions, 15 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
more ownership
Funds ownership: →
13% less capital invested
Capital invested by funds: $375M → $328M (-$47.2M)
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
Holders
70
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$6.81M | |
| 2 | +$1.29M | |
| 3 | +$1.24M | |
| 4 |
WP
Woodline Partners
San Francisco,
California
|
+$1.03M |
| 5 |
Charles Schwab
San Francisco,
California
|
+$792K |
Top Sellers
| 1 | -$12.1M | |
| 2 | -$6.99M | |
| 3 | -$1.18M | |
| 4 |
Bank of America
Charlotte,
North Carolina
|
-$163K |
| 5 |
Morgan Stanley
New York
|
-$143K |